For more than 50 years, Weill Cornell Medicine has combined its renowned expertise in kidney and pancreas transplantation with a patient-centered approach to provide compassionate, world-class care that maximizes patients’ quality of life, no matter how complicated their case may be.
The Kidney and Pancreas Transplant program at NewYork-Presbyterian/Weill Cornell Medical Center, in cooperation with the Rogosin Institute, has a history of excellence that extends to our beginning as the first kidney transplant program in New York state more than five decades ago.
Since then, we have continued to develop and offer all possible therapies for transplantation. Our skilled transplant surgeons also offer progressive therapeutic options not generally available through other transplantation programs, with rejection and survival rates that rival the national standards.
If there is a way to safely transplant a patient, we can do it!
The Kidney and Pancreas Transplant program at Weill Cornell Medicine is the largest of its kind in the United States, with more than 5,000 kidney transplants under our belt. Our program also has among the highest living donor kidney transplant volumes in the nation. In 2016, we ranked #1 on the East Coast and #2 in the U.S. for the number of living donor kidney transplant volumes. We are also a founding member center of the National Kidney Registry and have performed more than 150 living donor kidney transplants through Kidney Paired Donation.
Despite our size, our team of surgeons, physicians, nurses, transplant coordinators, physician assistants, social workers, pharmacists, and financial counselors offer excellent and personalized care for each person they treat.
We offer the very latest medical management protocols and surgical interventions, including advanced laparoscopic techniques for living kidney donors. And as one of the top academic medical centers in the country, our surgeons collaborate closely with researchers to translate scientific developments into new treatments and procedures that directly benefit our patients.
Our expertise extends to pancreas transplantation for patients with life-threatening complications of Type 1 diabetes mellitus. We were the first center in the New York Tri-State area to have performed successful human islet cell transplantation, a minimally invasive procedure to isolate the insulin-producing cells in the pancreas and implant them in a patient in order to improve control and reduce complications of Type 1 diabetes.
Weill Cornell Medicine also performs kidney transplantations in young patients through our Center for Pediatric Transplant and Advanced Kidney and Urologic Diseases.
This multidisciplinary pediatric kidney transplant program brings together a team of experts across multiple specialties, from transplant surgeons, pediatric nephrologists and pediatric urologists to pediatricians, psychiatrists, nutritionists, social workers, and pharmacists. Working together with patients and their families, this team provides seamless care throughout the child’s illness and treatment, pre- and post-surgery. Patients and family members also receive comprehensive transplant counseling throughout the process.
For more information, contact us today.
Weill Cornell Medicine has a history of excellence in patient care, offering cutting-edge therapies and individualized care throughout New York City. Learn more about the services we offer below.
Through extensive and innovative research programs, Weill Cornell Medicine is also focused on the development of new techniques and therapies that promote better outcomes and improve the quality of life for patients following surgery. Click here to learn more about our open clinical trials in New York City.